Skip to content

Study · Not a test of the peptide alone · 2013

1 result

Redox-dependent increases in glutathione reductase and exercise preconditioning: role of NADPH oxidase and mitochondria.

Frasier CR, Moukdar F, Patel HD, Sloan RC, Stewart LM, Alleman RJ, La Favor JD, Brown DA

Cardiovascular research22 Jan 2013Cited by 59 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Elamipretide (SS-31) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Elamipretide (SS-31).

  1. 01AnimalNot a test of Elamipretide (SS-31) aloneAnimal study (in vivo)Mechanism

    In rats, pretreatment with the mitochondrial reactive oxygen species reducers mitoTEMPO or Bendavia did not abolish the cardioprotective effects of exercise, unlike NADPH oxidase inhibitors.

    In plain wordsIn rats, mitochondria-targeted antioxidants, including Bendavia, did not remove the heart protection from exercise, unlike NADPH oxidase blockers.

    Outcome
    No significant changeExercise cardioprotection with mitochondrial ROS reducers (mitoTEMPO, Bendavia)
    Study

    ratn: not reported in source

    Exercise preconditioning, isolated heart ischaemia/reperfusion
    Outcome group
    Cardiovascular events · Cardiovascular

    Source sentences

    Summary
    The cardioprotective effects of exercise were abolished if animals exercised in the presence of NADPH oxidase inhibitors, in clear contrast to the mitochondrial reagents.
    2 context sentences
    Summary · context
    Rats were exercised for 10 consecutive days, after which isolated hearts were exposed to ischaemia/reperfusion (25 min/120 min).
    Summary · context
    Subsets of animals were exercised immediately after treatment with either NADPH-oxidase inhibitors apocynin or Vas2870, or with mitoTEMPO or Bendavia, which reduce mitochondrial reactive oxygen species levels.

    In this study, Elamipretide (SS-31) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Elamipretide (SS-31).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.